Cytel
↗Cambridge, MA, USA
Cytel is a global leader in clinical trial design, biostatistics, and data analytics for the pharmaceutical, biotechnology, and medical device industries. The company is best known for pioneering adaptive clinical trial designs, which allow for modifications to ongoing trials based on interim data without compromising statistical integrity. This approach significantly reduces the time, cost, and risk associated with drug development.
Beyond consulting services, Cytel provides industry-standard software solutions such as East®, the East Horizon™ platform (integrating Solara®), and EnForesee for enrollment forecasting. Their software is used by regulatory bodies, including the FDA and EMA, as well as the world's top 30 biopharmaceutical companies. Cytel operates as a specialized Contract Research Organization (CRO) and software-as-a-service (SaaS) provider, focusing on quantitative insights and evidence generation.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$200M-$500M
Founded:1987
Ownership:private
Status:operating
FUNDING
Stage:Acquired
Total Raised:$1000M+
Investors:Nordic Capital, Astorg, New Mountain Capital (Minority Stake), Merck Capital Ventures
PIPELINE
Stage:Service Provider
Lead Drug Stage:N/A
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Vaccines
Active Trials:450
Trial Phases:Phase 1: 110 | Phase 2: 180 | Phase 3: 150 | Phase 4: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Nordic Capital and Astorg
Acquired By:Nordic Capital and Astorg (Majority Stake) (2021-01-01)
Subsidiaries:SDS Life Science, SDS MedteQ, stève consultants, co.faktor, Axio Research, Purple Squirrel Economics
Key Partnerships:Bill & Melinda Gates Foundation (Global health analytics), FDA (Software licensing and training), OneMedNet (RWE data alliance)
COMPETITION
Position:Leader
Competitors:IQVIA, ICON plc, Medidata (Dassault Systèmes), Berry Consultants, Parexel, PPD (Thermo Fisher Scientific)
LEADERSHIP
Key Executives:
Jovan Willford - CEO
Yannis Jemiai - Chief Scientific Officer
Cyrus Mehta - Co-Founder & President
Scientific Founders:Cyrus Mehta, Nitin Patel
Board Members:David P. King (Chair; former Labcorp CEO), Daniel Berglund (Nordic Capital), Judith Charpentier (Astorg), Barry Gertz (Independent; former Merck SVP)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cytel. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.